{"groups":[{"description":"trientine dihydrochloride: trientine dihydrochloride 300MG/CAPSUE PO daily\n\npegylated liposomal doxorubicin: pegylated liposomal doxorubicin 40mg/m2 IV D1\n\ncarboplatin: carboplatin AUC 4 IV D1","id":"FG000","title":"Trientine With Chemotherapy Dose Level 1 (300mg)"},{"description":"trientine dihydrochloride: trientine dihydrochloride 600MG/CAPSUE PO daily\n\npegylated liposomal doxorubicin: pegylated liposomal doxorubicin 40mg/m2 IV D1\n\ncarboplatin: carboplatin AUC 4 IV D1","id":"FG001","title":"Trientine With Chemotherapy Dose Level 2 (600mg)"},{"description":"trientine dihydrochloride: trientine dihydrochloride 900MG/CAPSUE PO daily\n\npegylated liposomal doxorubicin: pegylated liposomal doxorubicin 40mg/m2 IV D1\n\ncarboplatin: carboplatin AUC 4 IV D1","id":"FG002","title":"Trientine With Chemotherapy Dose Level 3 (900mg)"},{"description":"trientine dihydrochloride: trientine dihydrochloride 1200MG/CAPSUE PO daily\n\npegylated liposomal doxorubicin: pegylated liposomal doxorubicin 40mg/m2 IV D1\n\ncarboplatin: carboplatin AUC 4 IV D1","id":"FG003","title":"Trientine With Chemotherapy Dose Level 4 (1200mg)"},{"description":"trientine dihydrochloride: trientine dihydrochloride 1500MG/CAPSUE PO daily\n\npegylated liposomal doxorubicin: pegylated liposomal doxorubicin 40mg/m2 IV D1\n\ncarboplatin: carboplatin AUC 4 IV D1","id":"FG004","title":"Trientine With Chemotherapy Dose Level 5 (1500mg)"},{"description":"trientine dihydrochloride: trientine dihydrochloride 1800MG/CAPSUE PO daily\n\npegylated liposomal doxorubicin: pegylated liposomal doxorubicin 40mg/m2 IV D1\n\ncarboplatin: carboplatin AUC 4 IV D1","id":"FG005","title":"Trientine With Chemotherapy Dose Level 6 (1800mg)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"}],"type":"The interruption in Trientine shippment"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"3"},{"groupId":"FG005","numSubjects":"2"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"3"},{"groupId":"FG005","numSubjects":"1"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"Between September 1, 2012 and October 30, 2015, eligible patients were enrolled in a medical center, National Cheng Kung University Hospital."}